Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mohamed A. Abou-Shady"'
Publikováno v:
The Egyptian Journal of Hospital Medicine. 76:4124-4132
Background: portal hypertension leads to the formation of portosystemic collateral veins in liver cirrhosis. Rupture of esophageal varices is common and can be fatal. Gastroesophageal varices are present in 50% of patients with cirrhosis. Their prese
Autor:
Mohamed A. Abou-Shady, Amr Elmestikawy, Dina H. Ziada, Ahmed Alwassief, Hossam Shahba, Ashraf Elbahrawy, Mohamed Abdelrazik
Publikováno v:
Journal of interferoncytokine research : the official journal of the International Society for Interferon and Cytokine Research. 39(9)
In the current study, we aimed to assess the efficacy of different Sofosbuvir (SOF)-based antiviral regimens available in Egypt in the treatment of Pegylated interferon/Ribavirin (PEG-INF/RBV)-experienced chronic hepatitis C virus (HCV) patients. Two
Autor:
Assem El-Sherif, Tsutomu Chiba, Yoshihide Ueda, Ashraf Elbahrawy, Mohamed A. Abou-Shady, Abdel Moneim Hosney, Hany Abou-Zeid, Ahmed Elwassief
Publikováno v:
Journal of Gastroenterology. 44:359-364
The presence of hepatitis B virus (HBV) DNA in liver tissue and/or in serum in the absence of detectable hepatitis B surface antigen (HBsAg) is called occult HBV infection. This pattern was identified in patients with chronic hepatitis C virus (HCV)
Autor:
Ashraf M. Al-Bahrawy, Mohamed A. Abou-Shady, Mohsen A. Al-Hiatmy, Elham A. Motawea, Assem El-Sherif
Publikováno v:
Hepatology International. 1:469-470
Regardless of all efforts to guarantee safety of blood, hepatitis B residual risk is the highest among transfusion-transmitted diseases [1]. HBV DNA was detected in 3.3% of blood donors negative for hepatitis B surface antigen (HbsAg) and hepatitis B
Autor:
Mohamed A. Abou-Shady, Assem El-Sherif, Abdel-Moneim M. Hosny, Reda M. Bakr, Ashraf M. Al-Bahrawy
Publikováno v:
Hepatology International
Introduction Patients with chronic liver disease ultimately progress to develop cirrhosis and portal hypertension. Recently it seems well established that nitric oxide disturbances play a key role in the pathogenesis of chronic liver disease and port